WR Wealth Planners LLC Decreases Position in The Cigna Group (NYSE:CI)

WR Wealth Planners LLC lessened its holdings in The Cigna Group (NYSE:CI) by 22.2% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 337 shares of the health services provider’s stock after selling 96 shares during the period. WR Wealth Planners LLC’s holdings in The Cigna Group were worth $93,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Prospera Private Wealth LLC purchased a new position in The Cigna Group in the 3rd quarter valued at approximately $37,000. Collier Financial purchased a new stake in shares of The Cigna Group during the 4th quarter worth $32,000. ORG Wealth Partners LLC purchased a new stake in shares of The Cigna Group during the 4th quarter worth $34,000. Harbor Capital Advisors Inc. purchased a new stake in shares of The Cigna Group during the 3rd quarter worth $45,000. Finally, Compagnie Lombard Odier SCmA purchased a new stake in shares of The Cigna Group during the 4th quarter worth $37,000. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on the stock. Wells Fargo & Company decreased their price objective on shares of The Cigna Group from $370.00 to $341.00 and set an “equal weight” rating for the company in a research report on Tuesday, February 4th. Stephens decreased their price objective on shares of The Cigna Group from $410.00 to $380.00 and set an “overweight” rating for the company in a research report on Friday, January 31st. UBS Group decreased their price objective on shares of The Cigna Group from $410.00 to $390.00 and set a “buy” rating for the company in a research report on Monday, February 3rd. Oppenheimer decreased their price objective on shares of The Cigna Group from $400.00 to $375.00 and set an “outperform” rating for the company in a research report on Friday, January 31st. Finally, Piper Sandler reiterated an “overweight” rating and set a $348.00 price target (down from $394.00) on shares of The Cigna Group in a research note on Monday, February 3rd. Two equities research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, The Cigna Group currently has an average rating of “Buy” and an average price target of $372.31.

The Cigna Group Trading Up 1.9 %

NYSE CI opened at $308.66 on Friday. The Cigna Group has a 52-week low of $262.03 and a 52-week high of $370.83. The company has a quick ratio of 0.72, a current ratio of 0.66 and a debt-to-equity ratio of 0.70. The stock has a market capitalization of $85.85 billion, a P/E ratio of 25.22, a P/E/G ratio of 0.98 and a beta of 0.54. The firm has a 50-day moving average price of $289.54 and a 200 day moving average price of $318.63.

The Cigna Group (NYSE:CI) last issued its earnings results on Thursday, January 30th. The health services provider reported $6.64 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.84 by ($1.20). The Cigna Group had a net margin of 1.39% and a return on equity of 18.61%. During the same quarter in the previous year, the firm earned $6.79 earnings per share. Equities research analysts expect that The Cigna Group will post 29.77 EPS for the current year.

The Cigna Group Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, March 20th. Stockholders of record on Wednesday, March 5th will be given a $1.51 dividend. The ex-dividend date is Wednesday, March 5th. This is a positive change from The Cigna Group’s previous quarterly dividend of $1.40. This represents a $6.04 annualized dividend and a dividend yield of 1.96%. The Cigna Group’s dividend payout ratio is currently 49.35%.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.